Healthcare provider profile · identity verified

Arseen E Soliman, M.D.

Internal Medicine · CONCORD, CA · NPI 1023034030

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	543	157
Amlodipine Besylate	Amlodipine Besylate	446	123
Lisinopril	Lisinopril	263	80
Metformin Hcl	Metformin Hcl	263	78
Levothyroxine Sodium	Levothyroxine Sodium	252	83
Losartan Potassium	Losartan Potassium	171	53
Simvastatin	Simvastatin	158	44
Gabapentin	Gabapentin	153	49
Tamsulosin Hcl	Tamsulosin Hcl	148	40
Rosuvastatin Calcium	Rosuvastatin Calcium	145	46
Trazodone Hcl	Trazodone Hcl	141	46
Pantoprazole Sodium	Pantoprazole Sodium	127	42
Hydrochlorothiazide	Hydrochlorothiazide	115	35
Glipizide	Glipizide	104	28
Metoprolol Succinate	Metoprolol Succinate	104	33
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	96	25
Lorazepam	Lorazepam	93	24
Omeprazole	Omeprazole	93	28
Carvedilol	Carvedilol	87	21
Albuterol Sulfate Hfa	Albuterol Sulfate	86	46
Alprazolam	Alprazolam	83	21
Allopurinol	Allopurinol	81	26
Citalopram Hbr	Citalopram Hydrobromide	81	25
Escitalopram Oxalate	Escitalopram Oxalate	81	25
Ezetimibe	Ezetimibe	80	22
Zolpidem Tartrate	Zolpidem Tartrate	74	31
Donepezil Hcl	Donepezil Hcl	66	18
Finasteride	Finasteride	66	19
Oxycodone Hcl	Oxycodone Hcl	61	suppressed
Potassium Chloride	Potassium Chloride	61	21
Sertraline Hcl	Sertraline Hcl	60	19
Metoprolol Tartrate	Metoprolol Tartrate	58	17
Atenolol	Atenolol	52	17
Famotidine	Famotidine	52	21
Eliquis	Apixaban	49	15
Metformin Hcl Er	Metformin Hcl	48	15
Fluticasone Propionate	Fluticasone Propionate	46	23
Glipizide Er	Glipizide	45	11
Tramadol Hcl	Tramadol Hcl	45	17
Clopidogrel	Clopidogrel Bisulfate	44	15
Furosemide	Furosemide	44	19
Januvia	Sitagliptin Phosphate	43	11
Lovastatin	Lovastatin	42	12
Azelastine Hcl	Azelastine Hcl	37	15
Trulicity	Dulaglutide	37	suppressed
Mirtazapine	Mirtazapine	36	12
Bupropion Hcl	Bupropion Hcl	35	12
Duloxetine Hcl	Duloxetine Hcl	35	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	35	suppressed
Ozempic	Semaglutide	35	suppressed
Pravastatin Sodium	Pravastatin Sodium	35	suppressed
Montelukast Sodium	Montelukast Sodium	34	suppressed
Bupropion Xl	Bupropion Hcl	33	suppressed
Azithromycin	Azithromycin	32	30
Diclofenac Sodium	Diclofenac Sodium	32	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	32	18
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	32	suppressed
Alendronate Sodium	Alendronate Sodium	31	13
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	31	25
Valsartan	Valsartan	31	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	30	suppressed
Arnuity Ellipta	Fluticasone Furoate	29	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	29	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	29	suppressed
Synthroid	Levothyroxine Sodium	29	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	29	suppressed
Benazepril Hcl	Benazepril Hcl	28	11
Clonidine Hcl	Clonidine Hcl	26	suppressed
Valacyclovir	Valacyclovir Hcl	25	11
Memantine Hcl	Memantine Hcl	23	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	23	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	22	20
Acetaminophen-Codeine	Acetaminophen With Codeine	21	suppressed
Celecoxib	Celecoxib	21	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	21	suppressed
Ibuprofen	Ibuprofen	21	12
Oxybutynin Chloride Er	Oxybutynin Chloride	21	suppressed
Aripiprazole	Aripiprazole	20	suppressed
Jardiance	Empagliflozin	20	suppressed
Methylprednisolone	Methylprednisolone	20	16
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	20	suppressed
Pregabalin	Pregabalin	20	suppressed
Tizanidine Hcl	Tizanidine Hcl	19	suppressed
Fluocinonide	Fluocinonide	18	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	18	suppressed
Myrbetriq	Mirabegron	18	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	18	suppressed
Ondansetron Hcl	Ondansetron Hcl	18	suppressed
Propranolol Hcl	Propranolol Hcl	18	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	18	suppressed
Cephalexin	Cephalexin	17	14
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	17	13
Doxycycline Monohydrate	Doxycycline Monohydrate	17	14
Morphine Sulfate	Morphine Sulfate	17	suppressed
Prednisone	Prednisone	17	suppressed
Primidone	Primidone	17	suppressed
Terazosin Hcl	Terazosin Hcl	17	suppressed
Baclofen	Baclofen	16	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	16	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	16	suppressed
Naproxen	Naproxen	16	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	15	15
Paxlovid	Nirmatrelvir/Ritonavir	15	15
Lansoprazole	Lansoprazole	14	suppressed
Meloxicam	Meloxicam	14	suppressed
Vascepa	Icosapent Ethyl	14	suppressed
Ventolin Hfa	Albuterol Sulfate	14	suppressed
Xarelto	Rivaroxaban	14	suppressed
Acyclovir	Acyclovir	13	suppressed
Breyna	Budesonide/Formoterol Fumarate	13	suppressed
Bupropion Hcl Sr	Bupropion Hcl	13	suppressed
Chlorthalidone	Chlorthalidone	13	suppressed
Lubiprostone	Lubiprostone	13	suppressed
Meclizine Hcl	Meclizine Hcl	13	suppressed
Morphine Sulfate Er	Morphine Sulfate	13	suppressed
Nifedipine Er	Nifedipine	13	suppressed
Solifenacin Succinate	Solifenacin Succinate	13	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	13	suppressed
Warfarin Sodium	Warfarin Sodium	13	suppressed
Zenpep	Lipase/Protease/Amylase	13	suppressed
Colchicine	Colchicine	12	suppressed
Estradiol	Estradiol	12	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	12	suppressed
Nebivolol Hcl	Nebivolol Hcl	12	suppressed
Nystatin	Nystatin	12	suppressed
Paroxetine Hcl	Paroxetine Hcl	12	suppressed
Rabeprazole Sodium	Rabeprazole Sodium	12	suppressed
Spironolactone	Spironolactone	12	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	11	suppressed
Mounjaro	Tirzepatide	11	suppressed
Sildenafil Citrate	Sildenafil Citrate	11	suppressed
Temazepam	Temazepam	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error